The February 2012 article by Goulart et al titled, “Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness,” (J Natl Compr Canc Netw 2012, doi: 10.6004/jnccn.2012.0023) was published with an error.
On page 267, in the last sentence in the right-hand column, a percentage given as a “high false-positive screening rate” from the National Lung Screening Trial (NLST) was actually a “high false discovery rate” in the NLST study. Thus, the sentence should have read: “The main concerns include the financial burden that a national [low-dose chest CT] screening program would imposed on the U.S. health care system, which currently struggles to contain escalating expenditures, and the patient burden that results from a high false discovery screening rate (estimated as 96.4% in the NCLS), including unnecessary costs and harms cause by additional imaging tests and surgical procedures.”
The journal apologizes for the error.
